We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Request Fewer Trials, Earlier Notice of Clinical Holds
Drugmakers Request Fewer Trials, Earlier Notice of Clinical Holds
July 20, 2011
As the FDA conducts a comprehensive review of its existing regulations ordered by President Barack Obama, the drug industry is taking the opportunity to seek fewer clinical trials to support drug approvals, and is asking for a revamp of the agency’s clinical hold policy and changes to its adverse event reporting policies.